587 related articles for article (PubMed ID: 24365191)
41. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
[TBL] [Abstract][Full Text] [Related]
42. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.
Krum H; Schlaich M; Whitbourn R; Sobotka PA; Sadowski J; Bartus K; Kapelak B; Walton A; Sievert H; Thambar S; Abraham WT; Esler M
Lancet; 2009 Apr; 373(9671):1275-81. PubMed ID: 19332353
[TBL] [Abstract][Full Text] [Related]
43. Renal denervation for resistant hypertension: acute results and long-term follow-up.
Korovesis S; Giazitzoglou E; Pantos I; Tzanalaridou E; Kokladi M; Venetsanakos I; Paxinos G; Katritsis DG
Hellenic J Cardiol; 2014; 55(3):211-6. PubMed ID: 24862613
[TBL] [Abstract][Full Text] [Related]
44. Renal sympathetic nerve ablation for the management of resistant hypertension: an update.
Thorp AA; Larsen RN; Schlaich MP
Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):607-14. PubMed ID: 24100214
[TBL] [Abstract][Full Text] [Related]
45. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
[TBL] [Abstract][Full Text] [Related]
46. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
[TBL] [Abstract][Full Text] [Related]
47. Renal Denervation.
Hameed MA; Dasgupta I
Adv Exp Med Biol; 2017; 956():261-277. PubMed ID: 27815927
[TBL] [Abstract][Full Text] [Related]
48. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
[TBL] [Abstract][Full Text] [Related]
49. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
Danilov NM; Matchin IuG; Chazova IE
Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
[TBL] [Abstract][Full Text] [Related]
50. [Renal denervation a new treatment option in resistant arterial hypertension].
Himmel F; Bode F; Schunkert H; Weil J
Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
[TBL] [Abstract][Full Text] [Related]
51. Renal Denervation to Modify Hypertension and the Heart Failure State.
Zhong M; Kim LK; Swaminathan RV; Feldman DN
Interv Cardiol Clin; 2017 Jul; 6(3):453-464. PubMed ID: 28600097
[TBL] [Abstract][Full Text] [Related]
52. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
Fengler K; Rommel KP; Hoellriegel R; Blazek S; Besler C; Desch S; Schuler G; Linke A; Lurz P
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515119
[TBL] [Abstract][Full Text] [Related]
53. Controversies related to renal artery denervation and devices.
Agwuegbo CC; Antia AU; Shamaki GR; Bob-Manuel T
Curr Opin Cardiol; 2024 Jul; 39(4):244-250. PubMed ID: 38567924
[TBL] [Abstract][Full Text] [Related]
54. Renal sympathetic denervation: hypertension therapy and beyond.
Williams PD; Whitbourn R
Expert Rev Med Devices; 2013 May; 10(3):329-38. PubMed ID: 23668705
[TBL] [Abstract][Full Text] [Related]
55. Renal denervation in patients with resistant hypertension: six-month results.
Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M
Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
[TBL] [Abstract][Full Text] [Related]
56. Renal denervation: transition from pathophysiology to clinical practice.
Gossios TD; Ziakas A; Doumas M; Katsiki N; Petroglou D; Kouparanis A; Lillis L; Karvounis H
Angiology; 2014 Oct; 65(9):760-8. PubMed ID: 24402321
[TBL] [Abstract][Full Text] [Related]
57. Renal Denervation: Where to Now?
Wimmer NJ; Mauri L
Curr Cardiol Rep; 2015 Dec; 17(12):116. PubMed ID: 26482759
[TBL] [Abstract][Full Text] [Related]
58. First-in-human use of the OneShot™ renal denervation system from Covidien.
Ormiston JA; Watson T; van Pelt N; Stewart R; Haworth P; Stewart JT; Webster MW
EuroIntervention; 2013 Jan; 8(9):1090-4. PubMed ID: 23339814
[TBL] [Abstract][Full Text] [Related]
59. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
Vink EE; Verloop WL; Siddiqi L; van Schelven LJ; Liam Oey P; Blankestijn PJ
Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168
[TBL] [Abstract][Full Text] [Related]
60. [The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].
Wang L; Lu CZ; Zhang X; Luo D; Zhao B; Yu X; Xia DS; Chen X; Zhao XD
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jan; 41(1):3-7. PubMed ID: 23651959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
